These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10846517)

  • 41. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mammographic density and breast cancer in three ethnic groups.
    Ursin G; Ma H; Wu AH; Bernstein L; Salane M; Parisky YR; Astrahan M; Siozon CC; Pike MC
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):332-8. PubMed ID: 12692108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women.
    Kabat GC; Kamensky V; Heo M; Bea JW; Hou L; Lane DS; Liu S; Qi L; Simon MS; Wactawski-Wende J; Rohan TE
    Maturitas; 2014 Sep; 79(1):70-6. PubMed ID: 25011395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hormonal and personal effects on estrogen receptors in breast cancer.
    Hulka BS; Chambless LE; Wilkinson WE; Deubner DC; McCarty KS; McCarty KS
    Am J Epidemiol; 1984 May; 119(5):692-704. PubMed ID: 6720668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mammographic density and breast cancer risk in White and African American Women.
    Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
    Breast Cancer Res Treat; 2012 Sep; 135(2):571-80. PubMed ID: 22864770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
    L'Hermite M
    Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective study of female hormone use and breast cancer among black women.
    Rosenberg L; Palmer JR; Wise LA; Adams-Campbell LL
    Arch Intern Med; 2006 Apr; 166(7):760-5. PubMed ID: 16606813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women.
    Wenten M; Gilliland FD; Baumgartner K; Samet JM
    Ann Epidemiol; 2002 Aug; 12(6):435-4. PubMed ID: 12160603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral contraceptives and breast cancer: a case-control study with hospital and community controls.
    Schildkraut JM; Hulka BS; Wilkinson WE
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):395-402. PubMed ID: 2381616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hormones and risk of breast cancer.
    Onnis A; Marchetti M; Graziottin A
    Eur J Gynaecol Oncol; 1983; 4(1):13-7. PubMed ID: 6305660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormone replacement therapy awareness in a biracial cohort of women aged 50-54 years.
    MacDougall LA; Barzilay JI; Helmick CG
    Menopause; 1999; 6(3):251-6. PubMed ID: 10486796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
    Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
    J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
    Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
    JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years.
    MacDougall LA; Barzilay JI; Helmick CG
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1203-11. PubMed ID: 10595334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Menopausal estrogen use and risk of breast cancer.
    Brinton LA; Hoover RN; Szklo M; Fraumeni JF
    Cancer; 1981 May; 47(10):2517-22. PubMed ID: 6268273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
    Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
    Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case-control study of body mass index and breast cancer risk in white and African-American women.
    Berstad P; Coates RJ; Bernstein L; Folger SG; Malone KE; Marchbanks PA; Weiss LK; Liff JM; McDonald JA; Strom BL; Simon MS; Deapen D; Press MF; Burkman RT; Spirtas R; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1532-44. PubMed ID: 20501755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.